Amgen investors await weight-loss drug data
By Deena Beasley (Reuters) - Amgen investors eyeing dramatic share price gains for rivals with successful obesity drugs will ...
15h ago
Bio-Techne beats third-quarter estimates on improving demand for biotech products
(Reuters) - Bio-Techne on Wednesday beat third-quarter profit and revenue estimates, helped by better-than-expected demand fo...
16h ago
Cencora beats profit estimates on strong demand for costly specialty drugs
(Reuters) - Cencora beat Wall Street estimates for second-quarter profit on Wednesday, driven by robust demand for costly spe...
16h ago
IDEXX Labs cuts 2024 revenue forecast on lagging vet visits, strong dollar
(Reuters) - IDEXX Laboratories lowered its annual sales forecast after missing quarterly estimates on Wednesday, as the anima...
16h ago
J&J advances $6.475 billion settlement of talc cancer lawsuits
By Dietrich Knauth NEW YORK(Reuters) - Johnson & Johnson is moving forward with a $6.475 billion proposed settlement of t...
16h ago
CVS cuts 2024 profit forecast as insurance unit faces soaring medical costs
(Reuters) -CVS Health Corp slashed its annual profit forecast and missed Wall Street estimates for first-quarter earnings on ...
17h ago
Pfizer lifts 2024 profit view on cost cuts, higher COVID vaccine demand
(Reuters) -Pfizer lifted its annual profit forecast on Wednesday, banking on cost cuts and better-than-expected demand for it...
17h ago
Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes
COPENHAGEN (Reuters) - Denmark will start putting patients suffering from type 2 diabetes on cheaper drugs before prescribing...
17h ago
Arizona Senate expected to vote on 1864 abortion ban repeal
By Brad Brooks (Reuters) - The Arizona Senate is expected to vote on Wednesday on a measure to repeal the state's 1864 ban on...
17h ago
Optomed Oyj, AEYE Health say portable device to detect eye issues gets FDA nod
(Reuters) - A portable device that detects eye conditions that can cause sight loss in people with conditions such as diabete...
17h ago